Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000488404) titled 'A Phase 1 Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MZE782 in Healthy Adults' on May 20.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Primary Sponsor: Maze Therapeutics
Condition:
Chronic Kidney Disease
Phenylketonuria
Chronic Kidney Disease
Phenylketonuria
Renal and Urogenital - Kidney disease
Human Genetics and Inherited Disorders - Other human genetics and inherited disorders
Metabolic and Endocrine - O...